Future of health
Backing pioneers who are transforming the health industry from digital therapeutics through to biotechnology.
“Healthy individuals are the backbone of our society and overall happiness. I feel privileged to back pioneering entrepreneurs who can make people live fuller lives and exceed expectations.”
Gian holds a degree in Industrial Economics from the University of Nottingham. He spent two months training in Muay Thai Boxing in Thailand and plans to spend two weeks a year training there.
“I get excited by the idea of searching for and backing companies that seek to positively impact millions, if not billions, of people around the world, as they redefine the Future of Health.”
Kamran holds a degree in Geography from the University of Oxford. He is an avid sportsman who enjoys playing football, tennis, golf, ping pong and competitive games of backgammon.
Luke joined Octopus Ventures in 2009 but began his career as a scientist, working to understand human disease using computational methods and big data, revealing the role that evolution played in disease development, before transitioning to Management and Technology Consultancy, specialising in the Capital Markets.
Alongside his role at Octopus, Luke is Chairman of UMI3, the University of Manchester’s technology transfer office. He also sits on the University’s Global Leadership Board. Luke holds a BSc (hons) in Biochemistry and Biotechnology, an MSc in Computational Biology and a PhD in Computational Genetics, all from the University of Manchester. When not at work, Luke likes to spend his time travelling, eating, training and doing stuff involving cars.
Prior to joining Octopus, Rebecca spent five years working in the Corporate Finance department at Deloitte, firstly in the Transaction Services department and later in the Corporate Finance Advisory division, where she was involved in a diverse range of M&A and capital market deals across a range of sectors.
Rebecca is a qualified chartered accountant, and has a first class honours degree in Accounting and Finance from the University of Southampton.
Uzma has been a research scientist in the fields of Photochemistry and Synthetic Biology. Whilst undertaking her PhD she worked with the University of Manchester Innovation Company to assess the commercial feasibility of technologies developed at the University, realising her passion for cutting edge technologies. Uzma joined the Ventures team in 2018.
“Through this experience I learnt about the many challenges of spinning out companies and taking disruptive innovations from the lab bench to the market.”
Uzma is focused on assessing investment opportunities, conducting preliminary due diligence and executing deals. Her experience straddles the Deep Tech and Future of Health Pods, and she is now focused on Frontier Technologies within health and biotech such as synthetic biology, nanotech, ‘omics, gene editing and computational biology and platforms at the intersection of technology and biology, including human augmentation and neurotech.
Uzma enjoys baking and cooking and has now equipped her kitchen to a semi-professional level!
“Healthcare feels like one of the ultimate places to build valuable businesses right now with so much latent consumer demand, especially in some of the least glamorous areas.”
Will studied Classical Archaeology and Ancient History at Oxford. Outside of work Will is a keen offshore sailor having sailed around Britain on two occasions as part of the Round Britain and Ireland race.
In the press
Will Gibbs reveals to TechCrunch how taboo healthcare subjects have huge potential markets
Cultural and institutional stigma has kept parts of healthcare out of sight and out of mind to all but the boldest entrepreneurs
Mental health investment reaches record high
Forbes reports on Kamran’s research into an area that presents massive potential for innovators and disruptors
Elvie’s femtech revolution
The Telegraph reports on Femtech superstar, Tania Boler